DR. DOMINIKI KATI
I am an experienced Life Sciences professional with significant exposure in the biotechnological and pharmaceutical industry for the past 6 years.
I have a rich academic background in Molecular Biology working in various research projects across different countries since 2012.
In 2015 I completed my Master of Science in Pharmaceutical Science with Distinction at Edinburgh Napier University, and shortly after graduating I began my career in R&D in Scotland, UK. I gained experience in leading and planning development activities and familiarized myself with validation requirements for in vitro diagnostics. My main focus was the technical transfer of processes from development to production in Switzerland.
In 2019 I worked in Medical and Commercial operations for a startup pharmaceutical services company in Dubai, UAE, having broad set of responsibilities across all business functions including medical and regulatory affairs.
In 2020, I started my journey in Pharmacovigilance with Genpharm Services, supporting the rare disease community in the MENA region. I am currently managing all pharmacovigilance activities in the region; I am responsible for the development and implementation of the internal Pharmacovigilance system, and I am acting as the Pharmacovigilance Officer for all safety reporting and monitoring.
In 2022, I was honored to receive the GCC Pharmacovigilance Award 2022 by the GCC Regulatory Affairs Pharma Summit.